@article{article, title  = {{P124 Long-term safety of radium-223 dichloride (Ra-223) in patients with castration-resistant prostate cancer (CRPC) and bone metastases from the phase 3 ALSYMPCA study}},

 publisher = {{Elsevier BV}},

 url = {{}},

 year = {{2013}},

 month = {{11}},

 author = {{Nilsson S and Schrader AJ and Kliment J and Solberg A and Franzén L and Bottomley D and Syndikus I and Parker C and Sartor O and Skjørestad I and Jensen T et al}},

 doi = {{10.1016/s1569-9056(13)62445-8}},

 volume = {{12}},

 journal = {{European Urology Supplements}},

 issue = {{6}},

 pages = {{178-178}},

 note = {{Accessed on 2025/10/10}}}